Tag
#SAN
-
2026
-
Seabridge Gold Reports Maiden Snip North Resource Estimate at Its Iskut Project in B.C.’s Golden Triangle
-
Stabilization Notice – Pre-Stab – NEW IMMO HOLDING
-
Pre-stabilisation Announcement
-
Sanofi: Information concerning the total number of voting rights and shares – March 2026
-
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
-
Decision to Issue Construction Permits for Seabridge Gold’s KSM Mitchell Treaty Tunnels Delayed
-
Webster Financial Corporation Announces Q1 2026 Earnings Release
-
Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians
-
Sanofi – Combined General Meeting of April 29, 2026 – Availability of Preparatory documents
-
Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP
-
Madison Air Launches Roadshow for Proposed Initial Public Offering
-
Seabridge Gold Provides Updated Mineral Resource Estimates for KSM Project
-
Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease
-
Press Release: AAD: new results from Sanofi’s amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
-
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
-
Seabridge Gold Files 2025 Annual Information Form, Year End Audited Financial Statements and MD&A
-
Linea Energy Closes Project Debt Financing for Watertown Solar in Michigan
-
Doral Renewables Secures Nearly $900 Million of Financing Commitments for Construction of Cold Creek Solar + Storage Project
-
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
-
Press release: Availability of the Q1 2026 aide-mémoire
-
Anew Climate Joins Carbon Measures to Advance Global Carbon Accounting Standards and Policies Supporting Market-Based Solutions
-
Tudor Abandons Appeal of the BC Chief Gold Commissioner’s Decision Pertaining to Seabridge Gold’s KSM’s Mitchell Treaty Tunnels (MTT)
-
Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Banco Santander, S.A. – SAN
-
rPlus Energies Secures Financing Commitments for 400-Megawatt Blacks Creek Energy Center